Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative esketamine infusion and postoperative sleep in patients with preoperative sleep disorders
ChiCTR2400079641Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine in sleep disorder (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Incidence of postoperative sleep disturbance on postoperative day 1. Started Jan 2024; status: recruiting.
02
Drugs
esketamine
03
Conditions
sleep disorder
Beyond the preview
Go deeper on ChiCTR2400079641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079641.